AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39

Authors: Klotz, L
Citation: L. Klotz, Combined androgen blockade in prostate cancer: meta-analyses and associated issues, BJU INT, 87(9), 2001, pp. 806-813

Authors: Hruby, G Choo, R Klotz, L Danjoux, C Murphy, J Deboer, G Morton, G Rakovitch, E Szumacher, E Fleshner, N
Citation: G. Hruby et al., The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer, BJU INT, 87(7), 2001, pp. 643-647

Authors: Klotz, L
Citation: L. Klotz, Cooperative group clinical trials: Canadian Urologic Oncology Group/GlobalGU Group, UROL ONCOL, 6(5), 2001, pp. 225-227

Authors: Crook, J Lukka, H Klotz, L Bestic, N Johnston, M
Citation: J. Crook et al., Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer, CAN MED A J, 164(7), 2001, pp. 975-981

Authors: Choo, R DeBoer, G Klotz, L Danjoux, C Morton, GC Rakovitch, E Fleshner, N Bunting, P Kapusta, L Hruby, G
Citation: R. Choo et al., PSA doubling time of prostate carcinoma managed with watchful observation alone, INT J RAD O, 50(3), 2001, pp. 615-620

Authors: Klotz, L
Citation: L. Klotz, An interpolation problem for Hilbert-Schmidt operator-valued stationary processes, Z ANAL ANWE, 20(2), 2001, pp. 525-535

Authors: Klotz, L
Citation: L. Klotz, Back to nephrectomy for patients with metastatic renal cancer, LANCET, 358(9286), 2001, pp. 948-949

Authors: Akduman, B Fleshner, NE Ehrlich, L Klotz, L
Citation: B. Akduman et al., Early experience in intermediate-risk penile cancer with sentinel node identification using the gamma probe, UROLOGY, 58(1), 2001, pp. 65-68

Authors: Klotz, L
Citation: L. Klotz, Catalog of prostate cancer nomograms - Comment, J UROL, 165(5), 2001, pp. 1568-1568

Authors: Klotz, L
Citation: L. Klotz, The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma - Comment, J UROL, 165(1), 2001, pp. 46-46

Authors: Elhilali, MM Gleave, M Fradet, Y Davis, I Venner, P Saad, F Klotz, L Moore, R Ernst, S Paton, V
Citation: Mm. Elhilali et al., Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma, BJU INT, 86(6), 2000, pp. 613-618

Authors: Klotz, L Garnick, M
Citation: L. Klotz et M. Garnick, Immunohistochemical changes in prostate cancer after androgen deprivation therapy - Open discussion following Dr. Bostwick's presentation, MOL UROL, 4(3), 2000, pp. 107-107

Authors: Fair, W Bostwick, D Civantos, F Klotz, L Cookson, M Sakr, W Garnick, M Stone, N Grignon, D
Citation: W. Fair et al., Epidemiology and molecular biology of early prostatic neoplasia - Open discussion following Dr. Sakr's presentation, MOL UROL, 4(3), 2000, pp. 115-115

Authors: Garnick, M Grignon, DJ Klotz, L Fair, W Bostwick, D Stone, N Porterfield, H Garzotto, M Moul, J Bruchovsky, N Heston, W
Citation: M. Garnick et al., Significance of the Gleason scoring system after neoadjuvant hormonal therapy - Open discussion following Dr. Grignon's presentation, MOL UROL, 4(3), 2000, pp. 131-131

Authors: D'Amico, A Garzotto, M Bruchovsky, N Sufrin, G Zietman, AL Stone, N Grignon, D Civantos, F Bostwick, D Klotz, L
Citation: A. D'Amico et al., Combined androgen deprivation with radiotherapy for prostate cancer: Does it make sense? Open discussion following Dr. Zietman's and Dr. Garzotto's presentations, MOL UROL, 4(3), 2000, pp. 215-215

Authors: Bruchovsky, N Howell, SB Garzotto, M Klotz, L
Citation: N. Bruchovsky et al., Resistance to apoptosis in prostate cancer cells - Open discussion following Dr. Howell's presentation, MOL UROL, 4(3), 2000, pp. 231-231

Authors: Klotz, L Gleave, M Goldenberg, SL
Citation: L. Klotz et al., Neoadjuvant hormone therapy: The Canadian trials, MOL UROL, 4(3), 2000, pp. 233-237

Authors: Garnick, M Klotz, L Moul, J Sylvester, J Stone, N
Citation: M. Garnick et al., Neoadjuvant hormone therapy: The Canadian trials - Open discussion following Dr. Klotz' presentation, MOL UROL, 4(3), 2000, pp. 239-239

Authors: Stone, N Fair, WR Grignon, D Bruchovsky, N Cookson, M Garnick, M Sylvester, J Klotz, L Zietman, A
Citation: N. Stone et al., Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer - Open discussion following Dr. Fair's presentation, MOL UROL, 4(3), 2000, pp. 249-250

Authors: Zietman, A Debruyne, FMJ Bruchovsky, N Klotz, L Fair, W
Citation: A. Zietman et al., Neoadjuvant hormonal therapy prior to radical prostatectomy: The European experience - Open discussion following Dr. Debruyne's presentation, MOL UROL, 4(3), 2000, pp. 257-257

Authors: Bostwick, D",Thrasher,"Klotz, L Fourcroy, J Stone, N
Citation: L. Bostwick, D",thrasher,"klotz et al., Comparative study of the clinical efficacy of two dosing regimens of flutamide - Open discussion following Dr. Thrasher's presentation, MOL UROL, 4(3), 2000, pp. 265-265

Authors: Phillips, C Gray, RE Fitch, MI Labrecque, M Fergus, K Klotz, L
Citation: C. Phillips et al., Early postsurgery experience of prostate cancer patients and spouses, CANCER PRAC, 8(4), 2000, pp. 165-171

Authors: Tsihlias, J Zhang, W Bhattacharya, N Flanagan, M Klotz, L Slingerland, J
Citation: J. Tsihlias et al., Involvement of p27(Kip1) in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells, ONCOGENE, 19(5), 2000, pp. 670-679

Authors: Van Poppel, H Nilsson, S Algaba, F Bergerheim, U Dal Cin, P Fleming, S Hellsten, S Kirkali, Z Klotz, L Lindblad, P Ljungberg, B Mulders, P Roskams, T Ross, RK Walker, C Wersail, P
Citation: H. Van Poppel et al., Precancerous lesions in the kidney, SC J UROL N, 34, 2000, pp. 136-165

Authors: Klotz, L
Citation: L. Klotz, An interpolation problem for multivariate stationary sequences, KYBERNETIKA, 36(3), 2000, pp. 321-327
Risultati: 1-25 | 26-39